Skip to content
AnalystLens

Illumina 8-K Report, Executive Changes (Jan 4, 2024)

Reports
Leadership Changes
Filing Date
Filed January 4, 2024
Period End
January 4, 2024
Security
ILMN
In the record · 2016–202610-K1110-Q338-K167

ILMN filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 167 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’17Nov ’17
  2. Material agreement8-K · Sep ’20Sep ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Material agreement8-K · Oct ’26Oct ’26

01—Abstract

Summary

Summary of the 8-K filed January 4, 2024. Cited figures are marked; the original filing is the authoritative source.

Illumina, Inc. filed this Current Report on Form 8-K dated January 4, 2024 to disclose a senior leadership change.

The company announced that Susan Tousi, Chief Commercial Officer, will leave the company effective January 5, 2024. The filing is limited to this personnel item under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). To cover the vacancy, Bas Verhoef, Head of Region Europe, will serve as Interim Chief Commercial Officer.

The filing does not state whether a permanent successor has been named, nor does it describe any severance or compensation arrangements tied to Ms. Tousi's departure. For investors, the filing signals a change in the commercial leadership team, with an interim executive now responsible for the commercial function. The filing contains no financial results, guidance, or operating metrics.

02—Key points

Key Highlights

  1. Susan Tousi, Chief Commercial Officer, is leaving Illumina, effective January 5, 2024.
  2. Bas Verhoef, Head of Region Europe, will serve as Interim Chief Commercial Officer.
  3. The announcement was disclosed under Item 5.02 of Form 8-K, covering officer departures and appointments.
  4. The filing does not name a permanent Chief Commercial Officer successor.
  5. The filing does not disclose any severance, compensation, or other financial terms related to the departure.
  6. No financial results, guidance, or operating metrics are reported in this filing.

03—Questions

Frequently Asked Questions

  1. Who is leaving Illumina and when?

    Susan Tousi, Chief Commercial Officer, will leave the company effective January 5, 2024, according to the January 4, 2024 announcement.

  2. Who will lead Illumina's commercial function in the interim?

    Bas Verhoef, Head of Region Europe, will serve as Interim Chief Commercial Officer.

  3. Has Illumina named a permanent Chief Commercial Officer?

    The filing does not mention a permanent successor; it only names an interim officer.

  4. Does this filing report financial results or guidance?

    No. This 8-K covers only the officer departure and interim appointment under Item 5.02.

04—Continue

← View all 8-K filings